Skip to main content
. 2019 Feb 15;33(2):838–845. doi: 10.1111/jvim.15426

Figure 1.

Figure 1

Treatment of PBMC from 6 healthy cats with LTC. A, OX40 expression by CD21+ B cells. B, OX40 expression by CD5+ T cells. C, MHCII expression by gated CD14+ monocytes. *, P < .05, **, P < .01 and ***, P < .005. LTC, liposome‐toll‐like receptor complexes; OX40, tumor necrosis factor receptor superfamily, member 4; PBMC, peripheral blood mononuclear cells